Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 6.532% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CCNC(=S)N/N=C/c1cc(C)ccc1C
b. CCN(C(=O)CSc1nnc2nc(C)cc(C)n12)c1ccccc1
c. CCOc1ccc(N(C)S(=O)(=O)c2ccc(-c3ccc(=O)[nH]n3)s2)cc1
d. Cc1sc2ncnc(Sc3ccccc3C(=O)O)c2c1C
Answer: b. CCN(C(=O)CSc1nnc2nc(C)cc(C)n12)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CSc1nnc2nc(C)cc(C)n12)c1ccccc1
CCN(C(=O)CSc1nnc2nc(C)cc(C)n12)c1ccccc1
2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)sulfanyl]-N-ethyl-N-phenylacetamide